Subscribe to Updates in Healthcare

RSS By Email

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines


The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

All GLG News Analyses Filed Under: Endocrinology

Articles with lock require a GLG News subscription
Glen McDaniel Posted April 30, 2007
"Ho Hum" to Abbott's Free Style Blood Glucose Meter
Analysis of: Abbott Announces FDA Clearance And Launch Of New FreeStyle Lite™ Blood Glucose Monitoring System | www.medicalnewstoday.com
Author: Glen McDaniel, President and Chief Executive Officer GM Global
  Abbott's new FreeStle meter does offer some good features, but it will be difficult for them to break through in a crowded market. Abbott needs to launch an adverising campaign to push the product even as it provides education as to how to best use the meter. Clinicians and Diabetes Educators...
Posted April 30, 2007
REVERSIBLE ERROR: Merck Receives Non Approvable Letter from FDA
Analysis of: Merck Receives Non Approvable Letter from FDA | home.businesswire.com
Author: GLG Member Program Contributor
  Merck & Co., Inc. has filed and NDA with the FDA. The FDA wants additional data in support of the benefit-to-risk profile for the proposed doses of ARCOXIA in order to gain approval.
Posted April 30, 2007
Stem cells for diabetes
Analysis of: Study Suggests Use Of Stem Cell Transplantation Is Beneficial Treatment Of Type 1 Diabetes | www.medicalnewstoday.com
Author: GLG Member Program Contributor
This seems more of an academic exercise than a true therapeutic option for diabetics.
Posted April 30, 2007
Is Bariatric surgery for type 2 diabetes mellitus an overly simplistic solution
Analysis of: Bariatric surgery - possible treatment for type 2 diabetes mellitus | www.news-medical.net
Author: GLG Member Program Contributor
There is reasonably good data emerging that bariatric surgery can be effective in treating obesity related complications.  However, as the prevalence of bariatric surgery increases in the U.S. in an exponential manner, there are many patients who have received this surgery without us knowing the...
Posted April 30, 2007
Better control vs. more side effects.
Analysis of: The Effect of Adding Exenatide to a Thiazolidinedione in Suboptimally Controlled Type 2 Diabetes | www.annals.org
Author: GLG Member Program Contributor
The incretin class of drugs are a good addition to our armamentarium of diabetes medication. The addition of Exanatide should improve control to whichever drug it is added to. The side effect profile, however, is an issue. Nausea may not be why people lose weight, but it is surely an issue when it comes...
Posted April 30, 2007
Cortisol and Psychiatric Disorders
Analysis of: Scientists unravel clue in cortisol production | www.rxpgnews.com
Author: GLG Member Program Contributor
Depression is associated with abnormalities in cortisol production, in the hypothalamic-pituitary-adrenal axis and related brain imaging abnormalitiesAnxiety disorders area associated with abnormalities in cortisol productionEating disorders are associated with abnormaliteis in cortisol production
Posted April 30, 2007
Simcor: Statin/Niacin is the Future
Analysis of: Abbott Submits New Drug Application For Combination Niaspan(R)/Simvastatin Tablet | www.medicalnewstoday.com
Author: GLG Member Program Contributor
1.  Physicians are realizing the huge importance of Outcome based trials in CV risk reduction2.  HATS in 2001 used Simvastatin + Niacin to achieve a 90% RRR in CV events3.  AIM-HIGH is going on now using Simvastatin + Niaspan (Simcor) to confirm these findings4.  Simcor should be...
Posted April 29, 2007
Thiazolidinedione + Incretins=Weight Loss + Improved Glycemic Control
Analysis of: The Effect of Adding Exenatide to a Thiazolidinedione in Suboptimally Controlled Type 2 Diabetes | www.annals.org
Author: GLG Member Program Contributor
Thiazolidinedione induced weight gain is mitigated with the addition of Exenatide, while improving glycemic control in Type 2 diabetes
Posted April 29, 2007
Bariatric Surgery: Too much, Too early.
Analysis of: Bariatric surgery - possible treatment for type 2 diabetes mellitus | www.news-medical.net
Author: GLG Member Program Contributor
Bariatric Surgery works to treat diabetes in the short run, but it is expensive and dangerous.
Posted April 29, 2007
Lantus and Levemir, Separating the Wheat From the Chaff
Analysis of: New Data Confirm That Use Of Levemir® Can Limit Weight Gain | www.medicalnewstoday.com
Author: GLG Member Program Contributor
Slight weight loss is demonstrated in a large observational study. This seems to support smaller studies. However, this is not a main advantage of Levemir.
Previous Page : 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 Next271 to 280 of 373

More GLG News in
Healthcare

Most Popular:
Source Article | Expert Analyses
 

GLG News: What Experts Think Is Important





Analytics


Generated at 2008-12-05T01:45:24.617